# The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

> **NCT05970185** · EARLY_PHASE1 · UNKNOWN · sponsor: **Zhongnan Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Granulocyte Colony-Stimulating Factor

## Interventions

- **DRUG:** PEG-rhG-CSF
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT05970185
- **Lead sponsor:** Zhongnan Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05970185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05970185, "The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05970185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*